A usability study of the closed-loop artificial pancreas was conducted on 40 insulin-dependent patients with type 2 diabetes (T2D) who were hospitalized in the general ward in the United Kingdom.
The study shows that the control of glycemia in patients with the closed-loop artificial pancreas is safe and in a better way in the hospital compared with the conventional insulin therapy.
The study has found the following benefits with the closed-loop artificial pancreas.
The artificial pancreas device is a reusable medical device. The device will cost around USD 8,600 with consumables.
Dr. Hood Thabit, the University of Cambridge has reported the study to the American Diabetes Association (ADA) during the annual scientific sessions.
A study at the Harvard School of Public Health has tracked the eating habits of about 100,000 people without diabetes for over 26 years. At the end of the study, more than 9,000 people are diagnosed with diabetes. The study has found the following.
Dr. Geng Zong says that preparing food from scratch is a better option instead of processed or refined foods in lowering the risk of type 2 diabetes.
The lead author of the study was Dr. Geng Zong. The study was published in the journal PLOS Medicine.
The accumulated and unwanted aggregates of proteins that become folded into fibrils or plaques in our body are called amyloids.
The amyloids are associated with more than 20 diseases such as Alzheimer's, Parkinson's and type 2 diabetes (T2D).
The amyloids will be formed as fibrils. The fibrils can destroy the cells in the pancreas leading to the insulin deficiency.
The deficiency of vitamin B12 can cause peripheral neuropathy and megaloblastic anemia.
An earlier study has indicated that a patient with diabetes is at a higher risk of cancer either before or after the diagnosis of diabetes.
Whenever a patient with diabetes takes additional medication to lower the high blood sugar levels, the symptoms of cancer increases.
The American Cancer Society says a patient with diabetes is at higher risk of colon cancer as both the diseases have common risk factors such as lack of physical activity (couch potato behavior), obesity and consuming red meat or processed meat.
A patient with type 2 diabetes (T2D) is at a higher risk of death with colon cancer.
The researchers have examined the data of more than one million adults for the incidents of cancer during their lifespan.
The study has found that 1.23 times increased the risk of cancer in just ten years prior to the diagnosis of diabetes.
Once a person is diagnosed with diabetes, the person may likely to get cancer.
Diabetes and cancer can be prevented with lifestyle changes along with diet modifications and physical exercise. The authors say that further study is required to find out the association between cancer and diabetes.
The lead author of the study was Dr. Iliana Lega. The study was published in the journal Cancer.
An earlier study shows that bariatric surgery can give relief from type 2 diabetes mellitus (T2D) in humans and rodents. The relief is not only to the weight loss but also helps in improving the glucose tolerance and insulin sensitivity, which indicate that the improvements are due to the role of gut microbiota.
The lead investigator of the study, Xiang Gao, Ph.D., says that the Duodenal-Jejunal bypass surgery (DJB) can be performed to cure type 2 diabetes of both genetic (mutation) and environmental (diet-induced) origin.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.